Last10K.com

Illumina, Inc. (ILMN) SEC Filing 10-K Annual Report for the fiscal year ending Sunday, January 1, 2023

SEC Filings

ILMN Valuations

Intrinsic Value
Financial Stability
Financial Ratios
Insider Trades
Manager Portfolios
Notifications

ILMN Annual Reports

ILMN Quarterly Reports

ILMN Corporate News

ILMN Merger Prospectus

Illumina Inc

HISTORY TOOLS
CIK: 1084961 Ticker: ILMN

Investors:
Salli Schwartz
+1.858.291.6421
ir@illumina.com
image1a.jpg
Media:
David McAlpine
+1.347.327.1336
pr@illumina.com
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2022

•Revenue of $1.08 billion for Q4 2022, down 10% from Q4 2021, and down 7% on a constant currency basis
•Revenue of $4.58 billion for fiscal year 2022, up 1% from fiscal year 2021, and up 3% on a constant currency basis
•GAAP diluted loss per share of $(0.89) for Q4 2022, compared to GAAP diluted earnings per share of $0.71 for Q4 2021
•Non-GAAP diluted earnings per share of $0.14 for Q4 2022, compared to non-GAAP diluted earnings per share of $0.75 for Q4 2021
•GAAP diluted loss per share of $(28.00) for fiscal year 2022, compared to GAAP diluted earnings per share of $5.04 for fiscal year 2021, and included $(24.93) per diluted share due to goodwill impairment related to the GRAIL segment and $(0.55) per diluted share due to an increase in tax expense from R&D capitalization requirements that were not repealed in Q4 2022
•Non-GAAP diluted earnings per share of $2.12 for fiscal year 2022, compared to non-GAAP diluted earnings per share of $5.90 for fiscal year 2021, and included $(0.55) per diluted share due to an increase in tax expense from R&D capitalization requirements that were not repealed in Q4 2022 and an increase in GRAIL’s non-GAAP operating loss due to a full year of consolidated results in 2022 compared to a partial year in 2021
•For fiscal year 2023, expect revenue to grow 7% to 10% compared to fiscal year 2022, GAAP diluted earnings per share of $0.03 to $0.28, and non-GAAP diluted earnings per share of $1.25 to $1.50

San Diego, February 7, 2023 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) today announced its financial results for the fourth quarter and fiscal year 2022, which include consolidated financial results for GRAIL.

“Our fourth quarter operating results were in line with our expectations, with ongoing traction across our product portfolio amid a challenging macroeconomic environment,” said Francis deSouza, Chief Executive Officer. “Illumina’s continued focus on innovation across multiple new products, including the NovaSeq X, the most powerful, most sustainable, and most cost-effective sequencer ever developed, have been met with strong customer interest. Our order book is exceeding expectations and we have begun shipping instruments. GRAIL ended the year with accelerating consumer excitement for its Galleri test; more than 4,500 health providers ordered the test in 2022, contributing to more than 60,000 tests ordered to date.”


The following information was filed by Illumina Inc (ILMN) on Tuesday, February 7, 2023 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Illumina Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Illumina Inc.

Continue

Assess how Illumina Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Illumina Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Audit Information
Cover Page
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Comprehensive Income (Loss)
Consolidated Statements Of Operations
Consolidated Statements Of Stockholders??? Equity
Acquisitions, Goodwill And Intangible Assets
Acquisitions, Goodwill And Intangible Assets (Tables)
Acquisitions, Goodwill And Intangible Assets - Narrative (Details)
Acquisitions, Goodwill And Intangible Assets - Schedule Of Amount Assigned To Identifiable Intangible Assets (Details)
Acquisitions, Goodwill And Intangible Assets - Schedule Of Changes In Goodwill (Details)
Acquisitions, Goodwill And Intangible Assets - Schedule Of Estimated Annual Amortization Of Intangible Assets (Details)
Acquisitions, Goodwill And Intangible Assets - Schedule Of Identifiable Intangible Assets (Details)
Acquisitions, Goodwill And Intangible Assets - Schedule Of Preliminary Fair Value Of Assets Acquired And Liabilities Assumed (Details)
Acquisitions, Goodwill And Intangible Assets - Schedule Of Pro Forma Information (Details)
Acquisitions, Goodwill And Intangible Assets - Schedule Of Total Purchase Price (Details)
Debt And Other Commitments
Debt And Other Commitments (Tables)
Debt And Other Commitments - Narrative (Details)
Debt And Other Commitments - Schedule Of Debt Conversions (Details)
Debt And Other Commitments - Schedule Of Debt Obligations (Details)
Debt And Other Commitments - Schedule Of Lease Costs (Details)
Debt And Other Commitments - Schedule Of Maturities Of Operating Lease Liabilities (Details)
Employee Benefit Plans
Employee Benefit Plans (Details)
Income Taxes
Income Taxes (Tables)
Income Taxes - Narrative (Details)
Income Taxes - Schedule Of (Loss) Income Before Income Taxes By Region (Details)
Income Taxes - Schedule Of Provision For Income Taxes (Details)
Income Taxes - Schedule Of Reconciliation Of Provision For (Loss) Income Taxes To Amount Computed By Applying The Federal Statutory Rate (Details)
Income Taxes - Schedule Of Significant Components Of Deferred Tax Assets And Liabilities (Details)
Income Taxes - Schedule Of The Gross Amount Of Uncertain Tax Positions (Details)
Investments And Fair Value Measurements
Investments And Fair Value Measurements (Tables)
Investments And Fair Value Measurements - Narrative (Details)
Investments And Fair Value Measurements - Schedule Of Changes In Estimated Fair Value Of Acquisition Related Contingent Consideration Liabilities (Details)
Investments And Fair Value Measurements - Schedule Of Hierarchy??For Assets And Liabilities Measured At Fair Value Recurring Basis (Details)
Investments And Fair Value Measurements - Schedule Of Marketable Equity Securities (Details)
Legal Proceedings
Legal Proceedings (Details)
Organization And Significant Accounting Policies
Organization And Significant Accounting Policies (Policies)
Organization And Significant Accounting Policies (Tables)
Organization And Significant Accounting Policies - Narrative - Advertising Costs (Details)
Organization And Significant Accounting Policies - Narrative - Concentrations Of Risk (Details)
Organization And Significant Accounting Policies - Narrative - Derivative Financial Instruments (Details)
Organization And Significant Accounting Policies - Narrative - Leases (Details)
Organization And Significant Accounting Policies - Narrative - Recently Adopted Accounting Policies (Details)
Organization And Significant Accounting Policies - Narrative - Revenue Recognition (Details)
Organization And Significant Accounting Policies - Narrative - Share-Based Compensation (Details)
Organization And Significant Accounting Policies - Narrative - Warranties (Details)
Organization And Significant Accounting Policies - Schedule Of Calculation Of Weighted Average Shares Used To Calculate Basic And Diluted Earnings (Loss) Per Share (Details)
Organization And Significant Accounting Policies - Schedule Of Estimated Useful Lives Of Major Classes Of Property And Equipment (Details)
Revenue
Revenue (Tables)
Revenue - Narrative - Contract Assets And Liabilities (Details)
Revenue - Narrative - Remaining Performance Obligation (Details)
Revenue - Schedule Of Disaggregation Of Revenue (Details)
Segments And Geographic Data
Segments And Geographic Data (Tables)
Segments And Geographic Data - Narrative (Details)
Segments And Geographic Data - Schedule Of Net Long-Lived Assets Consisting Of Property And Equipment (Details)
Segments And Geographic Data - Schedule Of Operating Performance And Assets By Segment (Details)
Stockholders' Equity
Stockholders' Equity (Tables)
Stockholders' Equity - Narrative (Details)
Stockholders' Equity - Narrative - Employee Stock Purchase Plan (Details)
Stockholders' Equity - Narrative - Liability-Classified Awards (Details)
Stockholders' Equity - Narrative - Restricted Stock (Details)
Stockholders' Equity - Narrative - Share Repurchases (Details)
Stockholders' Equity - Narrative - Share-Based Compensation (Details)
Stockholders' Equity - Narrative - Stock Options (Details)
Stockholders' Equity - Schedule Of Assumptions Used To Estimate The Weighted-Average Fair Value Per Share For Stock Purchase Under The Employee Stock Purchase Plan (Details)
Stockholders' Equity - Schedule Of Cash-Based Equity Incentive Award Activity (Details)
Stockholders' Equity - Schedule Of Pre-Tax Intrinsic Values And Total Fair Value Of Vested Restricted Stock (Details)
Stockholders' Equity - Schedule Of Restricted Stock Activity And Related Information (Details)
Stockholders' Equity - Schedule Of Share-Based Compensation Expense For All Stock Awards (Details)
Stockholders' Equity - Schedule Of Stock Option Activity Under All Stock Option Plans (Details)
Supplemental Balance Sheet And Statement Of Operations Details
Supplemental Balance Sheet And Statement Of Operations Details (Tables)
Supplemental Balance Sheet And Statement Of Operations Details - Narrative - Property And Equipment (Details)
Supplemental Balance Sheet And Statement Of Operations Details - Schedule Of Accounts Receivable (Details)
Supplemental Balance Sheet And Statement Of Operations Details - Schedule Of Accrued Liabilities (Details)
Supplemental Balance Sheet And Statement Of Operations Details - Schedule Of Changes In Reserve For Product Warranties (Details)
Supplemental Balance Sheet And Statement Of Operations Details - Schedule Of Inventory (Details)
Supplemental Balance Sheet And Statement Of Operations Details - Schedule Of Other (Expense) Income, Net (Details)
Supplemental Balance Sheet And Statement Of Operations Details - Schedule Of Property And Equipment (Details)
Ticker: ILMN
CIK: 1110803
Form Type: 10-K Annual Report
Accession Number: 0001110803-23-000023
Submitted to the SEC: Fri Feb 17 2023 4:06:30 PM EST
Accepted by the SEC: Fri Feb 17 2023
Period: Sunday, January 1, 2023
Industry: Laboratory Analytical Instruments

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/ilmn/0001110803-23-000023.htm